Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: the patient is a 69-year-old male with metastatic renal cell carcinoma admitted today to begin cycle 1 week 2 high-dose il-2 therapy. his oncologic history began in when a torso ct performed due to dyspnea was noted to have large right renal mass and multiple lung nodules. on he underwent right nephrectomy revealing renal cell carcinoma, clear cell type 6 cm, stage pt3an0. he was followed with scans every 4 months with stable pulmonary nodules noted. pet ct on showed multiple pulmonary nodules and mildly prominent mesenteric nodes. on , he underwent left lower lobe wedge resection with pathology from an 8 mm nodule consistent with metastatic renal cell carcinoma noted. followup torso ct revealed stable lung nodules but a new pancreatic mass. treatment options were discussed and high-dose il-2 therapy was recommended. he passed eligibility testing and began cycle 1 week 1 high-dose il-2 on receiving 11 of 14 doses. his course was complicated by mild toxic encephalopathy and acute renal failure. he is now recovered. he is being admitted for cycle 1 week 2 high-dose il-2 therapy. past medical history: kidney cancer as above, anxiety, hypercholesterolemia, right knee surgery, hypertension. allergies: previously reported myalgia secondary to statins, now tolerating low-dose simvastatin. social history: he lives in with his wife. has 3 adult daughters and 8 grandchildren. he previously ran a garage with significant exposure to asbestos, more recently sold kitchen cabinets. a 15-pack per year smoking history but 20 years ago. social etoh. no illicit drugs. medications: 1. celexa 20 mg per oral daily. 2. fish oil 1000 mg per oral daily. 3. aspirin 81 mg per oral daily. 4. amlodipine 2.5 mg per oral daily. 5. simvastatin 5 mg per oral daily. 6. niacin 125 mg per oral daily. 7. lorazepam 1 mg as needed. 8. atarax 10 mg as needed pruritus. 9. omeprazole 20 mg daily as needed for indigestion. 10.multivit 1 tablet daily. family history: noncontributory for kidney cancer. physical examination: general: well-appearing male in no acute distress. performance status 1. vital signs: 97.9, 92, 20, 112/64, o2 sat 98% on room air. heent: normocephalic, atraumatic. sclerae anicteric. moist oral mucosa without lesions. neck: supple. lymph nodes: no cervical, supraclavicular or bilateral axillary lymphadenopathy. heart: regular rate and rhythm. s1, s2. chest: clear bilaterally. abdomen: rounded, soft, nontender. extremities: no edema. skin: intact. neurologic exam: nonfocal. admission labs: wbc 5.7, hemoglobin 14.3, hematocrit 41.6, platelet count 453,000. inr 1.1. bun 18, creatinine 1.6. sodium 138, potassium 4.9, chloride 106, co2 of 22. alt 36, ast 26. ck 30. albumin 4.1. hospital course: the patient was admitted to begin therapy and underwent central line placement. his admission weight was 97 kg and he received interleukin-2, 600,000 international units per kilo equaling 49.7 million units based on adjusted ideal body weight. during this week he received 8 of 14 doses with dosing stopped early due to development of shock. on treatment day number 4, he was noted to be become hypotensive to systolic blood pressure of mid 80s without response to fluid boluses. he was initiated on dopamine blood pressure support. hypotension was treated with capillary leak syndrome from il-2 therapy. while on dopamine, he was noted to go into rapid atrial fibrillation with a heart rate between 160 and 180. he was transitioned off dopamine and changed to neo-synephrine but had a persistent rapid ventricular response and persistent hypotension noted. he was felt to require transfer to the icu to provide further blood pressure support and rate slowing agents. he transferred to the icu and was initially treated with diltiazem without response and persistent hypotension. he was subsequently placed on amiodarone with improvement in his heart rate and eventual conversion to normal sinus rhythm. he was slowly weaned off neo-synephrine and transferred back to the floor on . il-2 therapy was held at that time and blood pressure remained stable throughout the rest of his hospitalization. other side effects during this week included chills, nausea, vomiting, and diarrhea which resolved at the time of discharge. during this week he developed acute renal failure with a peak creatinine of 4.4 with associated oliguria. metabolic acidosis was noted with a minimum bicarb of 12 and improved with bicarb repletion up to 19. he had no transaminitis, myocarditis, or coagulopathy noted. he developed hyperbilirubinemia with a peak bilirubin of 3.3, improved to 3.2 at the time of discharge. he was anemic without need for packed red blood cell transfusion. he developed thrombocytopenia with a platelet count low 75,000 without evidence of bleeding. by , he had recovered for side effects to allow for discharge to home. condition on discharge: alert, oriented and ambulatory. discharge status: to home with his wife. discharge diagnoses: metastatic renal cell carcinoma status post cycle 1 week 2 __________ therapy complicated by shock, atrial fibrillation and acute renal failure. discharge medications: 1. acetaminophen 325 to 650 mg q.i.d. as needed for pain. 2. sarna lotion topically q.i.d. as needed for pruritus. 3. cephalexin 500 mg twice a day times 5 days. 4. citalopram 20 mg per oral daily. 5. lomotil 1-2 tabs q.i.d. as needed for loose stools. 6. lasix 20 mg per oral times 5 days or until you reach pre- treatment weight. 7. hydroxyzine 50 mg q.i.d. as needed for pruritus. 8. imodium 2-4 mg q.i.d. as needed for diarrhea. 9. lorazepam 0.5-1 mg 3 times daily as needed for nausea and vomiting. 10.prochlorperazine 10 mg q.i.d. as needed for nausea and vomiting. 11.eucerin cream topically. followup: the patient will return to clinic in 4 weeks after ct scans to assess disease response. i have reviewed the discharge summary as dictated by and agree with the course and disposition as noted. , md dictated by: medquist36 d: 19:43:42 t: 22:35:26 job#: procedure: venous catheterization, not elsewhere classified other cardiovascular stress test high-dose infusion interleukin-2 [il-2] diagnoses: acidosis pure hypercholesterolemia toxic encephalopathy unspecified essential hypertension acute kidney failure, unspecified atrial fibrillation personal history of tobacco use anxiety state, unspecified other shock without mention of trauma antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use gross hematuria secondary malignant neoplasm of lung personal history of malignant neoplasm of kidney acquired absence of kidney secondary malignant neoplasm of other digestive organs and spleen personal history of contact with and (suspected) exposure to asbestos jaundice, unspecified, not of newborn anorexia unspecified pruritic disorder drug-induced psychotic disorder with hallucinations other secondary thrombocytopenia encounter for antineoplastic immunotherapy 

Answer: The patient is high likely exposed to